Medical Director, Liver Transplant Program
Assistant Professor-Clinical, Gastroenterology, Hepatology and Nutrition
395 W. 12th Ave.
Columbus, Ohio 43210-1267
Background: Since joining as a faculty member in the Department of Gastroenterology, Hepatology and Nutrition (GHN) at the Ohio State Wexner Medical Center, I have been focused on strengthening and building our Hepatology division as well as our liver transplant program.
Through increased Hepatology and liver transplant referrals, the number of liver transplants done at our medical center continues to increase every year, while also maintaining and at times exceeding nationally recognized graft and patient survival outcomes.
We are also striving to provide exceptional service to our referring providers by improving clinic access and follow up, physician availability for consultation and outreach lectures, and through our telemedicine program in underserved areas.
Besides increasing the number of referrals, activations and liver transplantations at our medical center, my role as the Medical Director of Liver Transplantation has also focused on improving the care of these patients pre- and post-transplant. We now have multiple multidisciplinary committees that meet weekly, biweekly as well as monthly to discuss areas of improvement in our program. All of these committees serve the purpose of improving the quality of care that our pre- and post-liver transplant patients receive at our medical center.
It is an exciting time to be part of our excellent Hepatology division and liver transplant team. I will continue to strive to help lead our liver transplant program in becoming one of the nationally recognized leaders in liver transplantation.
- Viral hepatitis
- Portal hypertension
- Liver transplantation
A Pivotal, Within Subject, Comparison of the Escense Dx Liver Function Assessment (LFA) System to the Indocyanine Green Dye (IGD) Serum Retention Test in Patients With Impaired And Non-Impaired Hepatic Function (Cardiox). 2015. Co-Investigator.
A Prospective, Randomized Clinical Trial Comparing Blood Product Use and Bleeding Events During and After Endoscopic or Neurosurgical Procedures in Patients With Cirrhosis And Coagulopathy: Rotational Thromboelastrography (Rotem) Versus Conventional Therapy. (Scarlet). Pending. 2015-current. Co-investigator.
Optimizing Care for Hospitalized Patients With Cirrhosis: Midwest Cirrhosis Consortium. 2014-Current. Co-Investigator.
OCR002-HE209 (STOP-HE STUDY): Multicenter, Randomized Phase 2B Study to Evaluate the Efficacy, Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in Hospitalized Patients With Cirrhosis and Associated Hyperammonemia With an Episode of Hepatic Encephalopathy. 2014-Current. Co-Investigator.
Comparison of Body Mass Index to Visceral Adiposity Measured by Cross-Sectional Imaging in End-Stage Liver Disease. 2014-Current. Co-Investigator.
A Multicenter Group to Study Acute Liver Failure. 2014-Current. Co-Investigator.
Imaging-Based Hepatic Fat Quantification: Correlation With Histopathology. 2014-Current. Co-Investigator.
Magnetic Resonance Elastography. 2013-Current. Co-Investigator.
Acute Liver Failure Study Group Registry (Sponsor: Niddk). 2013-Current. Co-Investigator.
CPI-IFE-001: A Multicenter, Double-Blinded, Randomized, Controlled Study to Determine the Safety and Pharmokinetics of Ifetroban Injection in Hepatorenal Syndrome. February 2012-2016: Primary Investigator.
- Medical degree: The Ohio State University College of Medicine
- Residency: Internal Medicine, Ohio State University Wexner Medical Center
- Fellowship: Transplant, University of Florida Shands Hospital
- Fellowship: Gastroenterology, University of Florida Shands Hospital
2004 American Liver Foundation & American Association for the Study of Liver Diseases Resident Scholar Travel Award
2003 Letter of Commendation
2002 - 2003 Honors Program
2002 Letter of Commendation
2001 Honors Program
2001 Letter of Commendation
2002 Honors Program
Chapters in Books:
Hanje AJ, Michaels A, Lee WM. “N-Acetylcysteine has not been shown to be effective for all non-acetaminophen acute liver failure.” In Controversies in Hepatology. Edited by Jensen, DM. Thorofare: Slack, June 2011